Format

Send to:

Choose Destination
See comment in PubMed Commons below
Epidemiol Infect. 2008 Jan;136(1):44-55. Epub 2007 Mar 5.

Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom.

Author information

  • 1Section of Public Health and Health Policy, University of Glasgow, Glasgow, UK. p.lorgelly@clinmed.gla.ac.uk

Abstract

Rotavirus is the most common cause of gastroenteritis in children aged <5 years old, two new vaccines have recently been developed which can prevent associated morbidity and mortality. While apparently safe and efficacious, it is also important to establish whether rotavirus immunization is cost effective. A decision analytical model which employs data from a review of published evidence is used to determine the cost effectiveness of a rotavirus vaccine. The results suggest that some of the health sector costs, and all of the societal costs, of rotavirus gastroenteritis in children can be avoided by an immunization programme. The additional cost to the health sector may be considered worthwhile if there is a sufficient improvement in the quality-of-life of children and parents affected by gastroenteritis; this study did not find any evidence of research which has measured the utility gains from vaccination.

PMID:
17335631
[PubMed - indexed for MEDLINE]
PMCID:
PMC2870763
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Cambridge University Press Icon for PubMed Central
    Loading ...
    Write to the Help Desk